CLASS II ONGOING Device recall · Reported 13 Mar 2024 · FDA Enforcement Report

Synapse PACS recalled by FUJIFILM Healthcare Americas

FUJIFILM Healthcare Americas is recalling Synapse PACS, distributed nationwide in the US. The recall was initiated on 10 Jan 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware Version: 7.2.200, UDI: (01)854904006008(10)0702200
Quantity recalled12 Units (12 US)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1272-2024
FDA event ID
94090
Recalling firm
FUJIFILM Healthcare Americas, Lexington, MA
Classification
Class II
Status
Ongoing
Recall initiated
10 Jan 2024
FDA classified
7 Mar 2024
Reported
13 Mar 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

10 Jan 2024Recall initiated by company
7 Mar 2024Classified by FDA+57 days
13 Mar 2024Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Measurements on a Secondary Capture 2D image, that does not have pixel spacing in the DICOM header, when combined with a Breast Tomo Series results in incorrect measurements.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Synapse PACS - Version 7.2.200

Where it was distributed

Worldwide distribution - US Nationwide, including Puerto Rico and the countries of Australia, Belgium, Brazil, Canada, Colombia, Ecuador, France, Germany, India, Italy, Mexico, Namibia, Netherlands, Portugal, Qatar, Spain, Thailand, Turkey, UAE, United Kingdom.

Nationwide Puerto Rico

Questions about this recall

Is Synapse PACS recalled?

Yes. FUJIFILM Healthcare Americas recalled Synapse PACS on 10 Jan 2024. The recall is Class II and its status is Ongoing. Recall number Z-1272-2024.

Why was it recalled?

Measurements on a Secondary Capture 2D image, that does not have pixel spacing in the DICOM header, when combined with a Breast Tomo Series results in incorrect measurements.

Which lots are affected?

Software Version: 7.2.200, UDI: (01)854904006008(10)0702200

Where was it sold?

Worldwide distribution - US Nationwide, including Puerto Rico and the countries of Australia, Belgium, Brazil, Canada, Colombia, Ecuador, France, Germany, India, Italy, Mexico, Namibia, Netherlands, Portugal, Qatar, Spain, Thailand, Turkey, UAE, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from FUJIFILM Healthcare Americas

All 24

Other Other Medical Devices recalls

All 13,778